Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Lisco

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Frontiers in Endocrinology|October 2, 2023
Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life studySara Volpe, Giuseppe Lisco, Margherita Fanelli, et al.
Nutrients|April 12, 2025
The Effect of a Mediterranean Diet on Arterial Stiffness: A Systematic ReviewRoberta Zupo, Fabio Castellana, Giuseppe Lisco, et al.
Frontiers in Endocrinology|September 26, 2022
Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysisGiuseppe Lisco, Anna De Tullio, Olga Disoteo, et al.
Nutrients|January 11, 2024
Sarcopenia and Diabetes: A Detrimental Liaison of Advancing AgeGiuseppe Lisco, Olga Eugenia Disoteo, Anna De Tullio, et al.
Nutrients|November 11, 2022
Once-Weekly Subcutaneous Semaglutide Improves Fatty Liver Disease in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life StudySara Volpe, Giuseppe Lisco, Margherita Fanelli, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 20, 2024
Predicting Factors of Worse Prognosis in COVID-19: Results from a Cross-sectional Study on 52 Inpatients Admitted to the Internal Medicine DepartmentGiuseppe Lisco, Antonio Giovanni Solimando, Assunta Stragapede, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 3, 2021
TSH Variations in Chronic Heart Failure Outpatients: Clinical Correlates and OutcomesPaola Terlizzese, Miriam Albanese, Dario Grande, et al.
Journal of Clinical Medicine|July 2, 2021
COVID-19 and the Endocrine System: A Comprehensive Review on the ThemeGiuseppe Lisco, Anna De Tullio, Assunta Stragapede, et al.
Diabetes/Metabolism Research and Reviews|September 7, 2025
Incretin-Based Adjunct to Background Insulin Treatment for Managing Body Weight Excess in Type 1 Diabetes: An Expert Opinion Viewpoint From the Italian Association of Clinical EndocrinologistsGiuseppe Lisco, Anna De Tullio, Olga Eugenia Disoteo, et al.
Frontiers in Endocrinology|October 13, 2025
Predictive factors of body weight loss in patients with type 2 diabetes treated with GLP-1 receptor agonists: a 52-week prospective real-life studyAlfredo Vozza, Domenico Triggiani, Margherita Fanelli, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Frontiers in Endocrinology|October 2, 2023
Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life studySara Volpe, Giuseppe Lisco, Margherita Fanelli, et al.
Nutrients|April 12, 2025
The Effect of a Mediterranean Diet on Arterial Stiffness: A Systematic ReviewRoberta Zupo, Fabio Castellana, Giuseppe Lisco, et al.
Frontiers in Endocrinology|September 26, 2022
Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysisGiuseppe Lisco, Anna De Tullio, Olga Disoteo, et al.
Nutrients|January 11, 2024
Sarcopenia and Diabetes: A Detrimental Liaison of Advancing AgeGiuseppe Lisco, Olga Eugenia Disoteo, Anna De Tullio, et al.
Nutrients|November 11, 2022
Once-Weekly Subcutaneous Semaglutide Improves Fatty Liver Disease in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life StudySara Volpe, Giuseppe Lisco, Margherita Fanelli, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 20, 2024
Predicting Factors of Worse Prognosis in COVID-19: Results from a Cross-sectional Study on 52 Inpatients Admitted to the Internal Medicine DepartmentGiuseppe Lisco, Antonio Giovanni Solimando, Assunta Stragapede, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 3, 2021
TSH Variations in Chronic Heart Failure Outpatients: Clinical Correlates and OutcomesPaola Terlizzese, Miriam Albanese, Dario Grande, et al.
Journal of Clinical Medicine|July 2, 2021
COVID-19 and the Endocrine System: A Comprehensive Review on the ThemeGiuseppe Lisco, Anna De Tullio, Assunta Stragapede, et al.
Diabetes/Metabolism Research and Reviews|September 7, 2025
Incretin-Based Adjunct to Background Insulin Treatment for Managing Body Weight Excess in Type 1 Diabetes: An Expert Opinion Viewpoint From the Italian Association of Clinical EndocrinologistsGiuseppe Lisco, Anna De Tullio, Olga Eugenia Disoteo, et al.
Frontiers in Endocrinology|October 13, 2025
Predictive factors of body weight loss in patients with type 2 diabetes treated with GLP-1 receptor agonists: a 52-week prospective real-life studyAlfredo Vozza, Domenico Triggiani, Margherita Fanelli, et al.
Pageof 8